MS9427 is a potent PROTAC EGFR degrader that selectively degrades mutant EGFR (including L858R) via the ubiquitin-proteasome system (UPS) and autophagy-lysosome pathway without degrading wild-type EGFR; it exhibits strong inhibitory effects on NSCLC cell proliferation and can be used in anticancer research.